Cecily Jenkins
Community memory screening as a strategy for recruiting older adults into Alzheimer's disease research Alzheimers Res Ther. 2020 06 30; 12(1):78. . View in PubMed
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial JAMA Neurol. 2020 09 01; 77(9):1099-1109. . View in PubMed
Detection of Rater Errors on Cognitive Instruments in a Clinical Trial Setting J Prev Alzheimers Dis. 2018; 5(3):188-196. . View in PubMed
Temporal sequence learning in healthy aging and amnestic mild cognitive impairment Exp Aging Res. 2013; 39(4):371-81. . View in PubMed
When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's disease Am J Geriatr Psychiatry. 2010 Jul; 18(7):576-85. . View in PubMed
Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI Neurobiol Aging. 2008 Sep; 29(9):1285-95. . View in PubMed
Deterioration of visual-perceptual organization ability in Alzheimer's disease Cortex. 2007 Oct; 43(7):967-75. . View in PubMed
Effectiveness of support groups for people with mild to moderate Alzheimer's disease: an evaluative survey Am J Alzheimers Dis Other Demen. 2007 Feb-Mar; 22(1):14-9. . View in PubMed
Identification of Alzheimer disease risk by functional magnetic resonance imaging Arch Neurol. 2005 Dec; 62(12):1881-8. . View in PubMed
Incidence of and risk factors for hallucinations and delusions in patients with probable AD Neurology. 2000 May 23; 54(10):1965-71. . View in PubMed
The neuropsychology of aging Current Opinion in Psychiatry. 1994; 7:347-353. . View in PubMed
Structural organization of discourse production following right hemisphere damage Journal of Clinical and Experimental Neuropsychology. 1992; 14(1):40. . View in PubMed
Freebase cocaine and memory Comprehensive Psychiatry. 1990; 31(4):369-375. . View in PubMed
Characteristics of freebase cocaine psychosis The Yale Journal of Biology and Medicine. 1988; 61:115-122. . View in PubMed
Cloze analysis in schizophrenic speech: Scoring method and rater's education Perceptual and Motor Skills. 1988; 67:911-918. . View in PubMed
Semantic priming in thought disordered schizophrenic patients Schizophrenic Research. 1988; 1:61-66. . View in PubMed
Positive and Negative Symptoms of PsychosisIn P. Harvey and E. Walker (Eds. ), Lawrence Erlbaum Associates: Hillsdale, New Jersey. . Thought disorder and measured features of language production in schizophrenia. 1987. . View in PubMed
In her current position as Director of Neuropsychology at ATRI Dr. Jenkins plays a key role in the conduct of ATRI and the NIH funded Alzheimer’s Clinical Trials Consortium (ACTC). She manages the ACTC Clinical Outcome Instruments Unit, a team of internationally recognized experts advising ATRI and ACTC affiliated trialists and their academic/industry partners in selection of cognitive and clinical scales appropriate to the research questions. The team also provides operational guidance to promote clean data capture. Dr. Jenkins’ Neuropsychology team enforces rigorous training and certification standards for trial site personnel conducting cognitive assessments when these are primary study outcomes. She also directs expert quality review of collected data in select trials of disease-modifying interventions for pre-clinical Alzheimer’s Disease.